All posts by: Michael Zand

About Michael Zand

Can This Company Convince You to Love GMOs? – The Atlantic

Continue reading

2018-02-12 NEWS

The Atlantic

Can This Company Convince You to Love GMOs?
The Atlantic
The other founder was Tom Knight, a former MIT professor best known as the godfather of synthetic biology. From the start in 2009, Ginkgo’s team knew they wanted to make it easier to tinker with the DNA in yeast and bacteria. The basic technology has

Continue reading

2018-02-12 NEWS

Yale News

Researchers develop novel immunotherapy to target colorectal cancer
Yale News
Certain cancers fail to respond to existing immunotherapy drugs that are designed to unleash the body’s immune system against tumors. To investigate alternative approaches to these cancers, the Yale-led team focused on a protein molecule, DKK2, an

Continue reading

2018-02-12 NEWS

A clinical trial to test a gene therapy treatment for a rare liver disease
EurekAlert (press release)
The technology used in the trial was developed by the ‘Immunology and Gene Therapy for Liver Disease’ team at Généthon, headed by Dr Federico Mingozzi. In partnership with research teams in Italy and the Netherlands, Généthon has developed an Adeno